Abstract
We have previously demonstrated that Captopril, an inhibitor of angiotensin converting enzyme (ACE), ameliorates experimental systemic lupus erythematosus in inbred MRL lpr/lpr (MRL/l) mice. In contrast, Enalapril, another ACE inhibitor with antihypertensive properties but lacking a thiol group, did not show similar beneficial effects. To better understand the mode of action of captopril in the autoimmune disease we have evaluated its immunomodulatory properties with special emphasis on antigen-specific and polyclonal B- and T-cell activation. The results obtained strongly suggest that Captopril exerts its immunomodulatory effects through stimulation of T-lymphocytes.
References
J. Lieberman,Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis. Am. J. Med.59, 365–372 (1975).
H. Herlitz, A. Tarkowski, C. Svalander, R. Volkmann and G. Westberg,Beneficial effect of captopril on systemic lupus erythematosus-like disease in MRL lpr/lpr mice. Int. Archs Allergy appl. Immun.85, 272–277 (1988).
H. Herlitz, C. Svalander, A. Tarkowski and G. Westberg,Influence of antihypertensive treatment on renal and extrarenal lupus manifestations in MRL/l mice. Scand. J. Urology Nephr. (S)108, 65–70 (1988).
H. Van Loveren, K. Kato, R. E. Ratzlaff, R. Meade, W. Ptak and P. A. Askenase,Use of micrometers and calipers to measure various components of delayed-type hypersensitivity ear swelling reactions in mice. J. Immunol. Meth.67, 311–319 (1984).
H. Carlsten, L.-Å. Nilsson and A. Tarkowski,Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int. Archs Allergy appl. Immun.81, 322–325 (1986).
A. Tarkowski, R. Jonsson, R. Sanchez, L. Klaresog and W. J. Koopman,Features of renal vasculitis in autoimmune MRL lpr/lpr mice: phenotypes and functional properties of infiltrating cells. Clin. exp. Immunol.72, 91–97 (1988).
H. Carlsten and A. Tarkowski,Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation. Scand. J. Immunol.30, 457–462 (1989).
S. Gillis, M. M. Ferm, W. Ou and K. A. Smith,T-cell growth factor: parameters of production and quantitative microassay for activity. J. Immunol.120, 2027–2031 (1978).
N. Lycke, A.-K. Bromander, L. Ekman, U. Karlsson and J. Holmgren,Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J. Immunol.142, 20–27 (1989).
G. Mancini, A. O. Carbonara and J. F. Heremans,Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry2, 235–254 (1965).
R. T. Wold, F. E. Young, E. M. Tan and R. S. Farr,Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science161, 806–807 (1968).
G. Lindstedt, P.-A. Lundberg, S. Ivarson and J. Lindberg,Circulating heat-labile DNA binder(s) in chronic active hepatitis and rheumatoid arthritis. Clin. Chim. Acta62, 183–186 (1975).
M. W. Russel, T. A. Brown, J. Radl, J. J. Haaijman and J. Mestecky, Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J. Immunol. Methods87, 87–93 (1986).
H. Elwing and H. Nygren,Diffusion-in-gel enzyme-linked immunosorbent assay (DIG-ELISA): a simple method for quantitation of class-specific antibodies. J. Immunol. Methods31, 101–108 (1979).
A. Tarkowski, C. Czerkinsky and L.-Å. Nilsson,Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/l mice: a kinetic study. Clin. exp. Immunol.58, 7–12 (1984).
J. P. Henry, J. B. Meehan, P. Stephens and G. A. Santesteban,Arterial pressure in CBA mice as related to age. J. Geront.20, 239–243 (1965).
D. Wofsy and W. E. Seaman,Successful treatment of autoimmunity of NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J. Exp. Med.161, 378–391 (1985).
W. E. Seaman, D. Wofsy, S. Greenspan and J. A. Ledbetter,Treatment of autoimmune MRL/lpr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease. J. Immunol.130, 1713–1718 (1983).
C. Scott, M. Tsurfuji, C. Lu, R. Finberg and M.-S. Sy,Comparison of antigen-specific T-cell responses in autoimmune MRL MP-lpr/lpr and MRL Mp +/+ mice. J. Immunol.132, 633–639 (1984).
G. S. Deepe, C. L. Taylor, L. Srivastava and W. E. Bullock,Impairment of granulomatous inflammatory response to histoplasma capsulatum by inhibitors of angiotensin-converting enzyme. Infect. Immunity48, 395–401 (1985).
S. A. Johnsen and M. Aurell,Immunosuppressive action of captopril blocked by prostaglandin synthetase inhibitor. Lancet1, 1005 (1981).
G. J. Prud'homme, T. M. Fieser, F. J. Dixon and A. N. Theofilopoulos,B-cell tropic interleukins in murine systemic lupus erythematosus (SLE) 1. Immunol. Rev.78, 159–183 (1984).
M. Kiyotaki, T. Toguchi, T. Abe, T. Takeuchi, C. Morimoto and M. Homma,In vitro anti-DNA antibody synthesis by peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clin. Immunol. Immunopath.21, 237–246 (1981).
J. F. Delfraissy, P. Galanaud, J. F. Balavoine, C. Wallon and J. Dormont,Captopril and immune regulation. Kidney Int.25, 925–929 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tarkowski, A., Carlsten, H., Herlitz, H. et al. Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease. Agents and Actions 31, 96–101 (1990). https://doi.org/10.1007/BF02003227
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02003227